Organization · Corporate Venture Capital
LifeArc Ventures
LifeArc Ventures is the venture capital arm of the medical research charity LifeArc, based in the UK. It invests in early-stage, science-led life science companies, focusing on therapeutics, HealthTech, and medical devices.
Overview
What LifeArc Ventures does
What LifeArc Ventures is
LifeArc Ventures is the venture capital arm of the medical research charity LifeArc, based in the UK. It invests in early-stage, science-led life science companies, focusing on therapeutics, HealthTech, and medical devices.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find LifeArc Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
LifeArc Ventures as a funder
Investment thesis
LifeArc Ventures invests in science-led companies that can benefit from translational support and venture funding, focusing on therapeutics, HealthTech, and MedTech.
Focus narrative
LifeArc Ventures primarily invests in Seed and Series A funding rounds, with potential for significant follow-on investments in successful portfolio companies. The organization emphasizes translational scientific research and seeks to support companies with protectable intellectual property and outstanding scientific founders, primarily within the UK but also globally.
Value beyond capital
LifeArc Ventures provides not only capital but also strategic advice, board-building support, and access to LifeArc's scientific resources and industry network, enhancing the probability of clinical and commercial success for its portfolio companies.
Focus and fit
- Stages
- Seed · Series A · Series B
- Regions
- Uk · Europe · United States · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
Notable portfolio companies include: Exciva: Developing therapies to improve quality of life in Alzheimer's disease. GlycoEra: Focused on developing protein degraders for autoimmune diseases. Tribune Therapeutics: Creating novel medicines to treat fibrosis. Fluid Biomed: Commercializing a polymer-based brain stent for aneurysms. Cumulus Neuroscience: Monitoring central nervous system diseases with a digital biomarker platform.
Common questions
What to know about LifeArc Ventures
Upseed classifies LifeArc Ventures under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.